GLP-1 GLP-1 GLP-1 GLP-1 GLP-1 GLP-1 GLP-1 GLP-1Glucagon-Like Peptide-1 2 GLP-1 GLP-1 GLP-1[1] GLP-1 GLP-1 GLP-1 GLP-1 GLP-1 GLP-1 GLP-1 GLP-1 23 12 BMI GLP-1 GLP-1 1 120mL30 GLP-1 11 1 GLP-1 GLP-1 GLP-1 [2] GLP-1 3mg2.5mg GLP-1 BMI BMIGLP-1 GLP-1 GLP-1 GLP-1 GLP-1 GLP-1 GLP-1 GLP-1 GLP-1 GLP-1 111 GLP-1 GLP-123 GLP-1 GLP-1 4 BMI BMI BMIkgm GLP-1BMI23 BMI BMI23GLP-1 BMI2535 GLP-1BMI20 GLP-1 GLP-1 1 GLP-111.5kg 110kg BMI GLP-1 GLP-1 GLP-1 GLP-1 GLP-1 GLP-1 30 (GLP-1)PSC GLP-1 GLP-1 BMI GLP-1 [1]Megha Pawar,Chandrashekhar Patil,Zubershaha Fakir,Durgesh Pagar.GLP-1 Receptor Agonists: Advances in Mechanism, Therapeutic Applications, and Future Perspectives.November 2025BioMed Target Journal [2]Taheri, S., et al.Short Sleep Duration Is Associated with Reduced Leptin, Elevated Ghrelin, and Increased Body Mass Index.PLoS Medicine, 2004 GLP-1 11 GLP-1 GLP-1GIP2 [ ] 10:3019:00 DOCTOR
E., Bush, M
The skin is an effective barrier that stops large molecules from passing through it and into the bloodstream
GLP-1 drugs, which mimic one or more gut hormones, act on the body in ways both known and yet to be discovered
Therefore, we focus on the biological characteristics of GLP-1, render an overview of the mechanism of GLP-1 effects in diseases, and investigate the potential of GLP-1 analogues for the treatment of related diseases in this review